Archive · Ars Technica
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
ZAZTEK archives the headline, summary and publication date so the story stays findable. The full article remains the publisher's. Read it at Ars Technica →